Zura Bio Inc

This study tests a new drug, tibulizumab, in 225 adults with hidradenitis suppurativa (HS), a painful skin condition. For the first 16 weeks, some participants get the drug and some get a placebo. Then everyone gets the drug for another 16 weeks. The main goal is to see if the dr…

This study tests a new medicine called tibulizumab for adults with systemic sclerosis, a disease that causes skin thickening and can affect internal organs. About 80 people will take part, first in a blinded phase where some get the drug and some get a placebo, then everyone gets…